Used primarily in the pharmaceutical industry as an intermediate in the synthesis of xanthine derivatives, this compound plays a role in developing drugs that target respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Its structure supports the creation of bronchodilators that help relax and open air passages in the lungs. Additionally, it has been explored for use in anti-inflammatory and neuroprotective agents due to its ability to interact with adenosine receptors in the central nervous system. Its thioxo modification enhances metabolic stability, making it valuable in improving drug half-life and efficacy.